| Aspect | Tivara | Hyro | Assort Health |
|--------|--------|------|--------------|
| Starting Price | Not publicly listed (quote-based) | Not publicly listed (quote-based) | Third-party reporting indicates enterprise annual contracts with a wide range depending on deployment scope |
| Best For | Specialty medical groups seeking voice automation with EHR/PM workflow writeback | Larger health systems requiring multi-channel agents, published benchmarks/case studies, and explicit responsible AI controls | Organizations seeking call center/scheduling automation under enterprise contracts and performance-based components |
| Key Strength | Focus on phone workflows (scheduling, refills, intake, after-hours) with EHR/PM writeback and escalation to human staff for low-confidence calls | Publishes measurable operational metrics and emphasizes multi-channel automation and compliance controls | Positioned for enterprise scheduling/call center automation with scope-based contracting and pricing intelligence |
| Key Weakness | Limited independent review coverage and limited public documentation (pricing, detailed security artifacts, case studies) | Pricing opacity; may be heavyweight for very small clinics | Potentially expensive for smaller clinics; implementation scope can be complex |
- Direct competitors and their key differentiators
- Hyro
- Emphasizes responsible AI controls (control, explainability, compliance) and publishes case metrics.
- Positions across multiple channels beyond phone (web/SMS).
- Assort Health
- Positioned around call center/scheduling automation; third-party sources describe enterprise annual contract pricing and scope-based scaling.
- Prior authorization-focused vendors (adjacent)
- SamaCare and Humata Health specialize in PA workflows and may provide deeper policy and submission workflows than a general voice agent—relevant if PA automation is the primary requirement.
- Feature comparison: where does Tivara excel vs lag behind?
- Potential strengths (based on Tivara messaging)
- Automation of multiple phone workflows with EHR/PM writeback and policy to escalate low-confidence calls to human staff.
- Potential gaps / unknowns
- Lack of public evidence for resolution rates, containment percentage, appointment capture lifts, and similar operational metrics.
- Limited public trust center materials beyond HIPAA and SOC 2 claims.
- Pricing comparison: value proposition vs alternatives
- Tivara: opaque pricing; requires a sales process and quote.
- Assort Health: third-party research suggests enterprise-level annual contracts with substantial variability based on scope.
- Hyro: third-party commentary references enterprise-level starting costs; official pricing disclosures are not public.
- Customer testimonials comparing this product to competitors
- No Tivara-specific comparative user reviews were found in accessible sources.
- Market share and adoption trends
- Industry context: by early 2026 there are multiple companies marketing autonomous phone agents for scheduling, indicating a crowded market where integration depth and outcome validation are key differentiators.
- When customers choose competitors instead (and why)
- Competitors may be chosen when:
- A multi-channel digital front door, mature analytics, and published controls/benchmarks are required (Hyro).
- An organization prefers a vendor positioned for enterprise call center/scheduling automation with established contracting models (Assort Health).
- Prior authorization automation is the core problem (SamaCare, Humata Health).